Genelux (GNLX)
Develops Olvi-Vec, an oncolytic virus therapy for platinum-resistant ovarian cancer.
$2.52
vs last close−0.09 (−3.45%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
estimated · in 42 days
EPS estimate
−$0.20
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.26−$0.21−$0.20−$0.21−$0.24−$0.20−$0.21Pending
Estimate−$0.17−$0.24−$0.22−$0.23−$0.22−$0.18−$0.20−$0.20
Surprise−52.9%+12.5%+9.1%+8.7%−9.1%−11.1%−6.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$452.0K———$8.0K——Pending
Estimate————$8.0K———
Surprise————0.0%———
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.18 | — | — |
| Sep 2027 | −$0.18 | — | — |
| Jun 2027 | −$0.20 | — | — |
| Mar 2027 | −$0.17 | — | — |
| Dec 2026 | −$0.20 | — | — |
| Nov 2026 | −$0.20 | — | — |
| Aug 2026 | −$0.20 | −$0.21 | −6.8% |
| May 2026 | −$0.18 | −$0.20 | −11.1% |
| Mar 2026 | −$0.22 | −$0.24 | −9.1% |
| Nov 2025 | −$0.23 | −$0.21 | +8.7% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Jan 2023 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.18 | — | — | $4.0M | — | — | — |
| Sep 2027 | −$0.18 | — | — | $2.0M | — | — | — |
| Jun 2027 | −$0.20 | — | — | $3.2M | — | — | — |
| Mar 2027 | −$0.17 | — | — | $3.1M | — | — | — |
| Dec 2026 | −$0.20 | — | — | $0 | — | — | — |
| Nov 4, 2026 | −$0.20 | — | — | $0 | — | — | — |
| Aug 13, 2026 | −$0.20 | −$0.21 | −6.8% | — | — | — | +4.2% |
| May 7, 2026 | −$0.18 | −$0.20 | −11.1% | — | — | — | −1.4% |
| Mar 19, 2026 | −$0.22 | −$0.24 | −9.1% | $8.0K | $8.0K | 0.0% | −1.9% |
| Nov 5, 2025 | −$0.23 | −$0.21 | +8.7% | — | — | — | −3.3% |
| Aug 7, 2025 | |||||||
| May 6, 2025 | |||||||
| Mar 28, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 29, 2023 | |||||||
| Jan 26, 2023 | |||||||
| Sep 30, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |